North America Radiotherapy Market Size and Forecast (2021-2031)
North America Radiotherapy Market Size and Forecast (2021-2031), Regional and Country Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Products and Software), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, and Others), End User (Hospitals, Radiation Therapy Centers, and Specialty Clinics), and Geography
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
The North America radiotherapy market forecast presented in this report can help stakeholders in this marketplace plan their growth strategies. The surging prevalence of cancer and preference for rapid diagnostic solutions are the key factors propelling the market development. Key factors driving the market growth include rising cancer prevalence and increasing conferences and symposiums to boost awareness about radiation therapy.
Market Opportunities of North America Radiotherapy Market
Programs for illness diagnosis and preventive healthcare are becoming more widely used in North America. For example, breast cancer screening programs are available in all Canadian provinces for women between the ages of 50 and 74. The Provincial Health Services Authority of British Columbia offers a breast cancer screening program to a broad population base at a low cost. The program’s primary goal is to detect breast cancer early. Furthermore, the World Health Organization (WHO) declared in November 2020 the start of a strategic initiative to expedite the eradication of cervical cancer. The organization declared that vaccination, screening, and treatment are the three essential steps to achieving the goal. The Comprehensive Cancer Control National Partnership (CCCNP) also counts the CDC among its 19 member national organizations. Its primary objective is to support all-encompassing cancer control coalitions in states, territories, tribes, and U.S. Pacific Island jurisdictions. These initiatives will probably increase the number of cancer cases diagnosed, fostering a favorable atmosphere for radiotherapy adoption in the area.
Implementing strategic directives and policies is the main priority for governments and healthcare institutions. For example, to increase access to radiotherapy globally, the WHO and the International Atomic Energy Agency (IAEA) worked together to release new guidelines in March 2021 centered on purchasing radiotherapy. The selection, use, and upkeep of radiotherapy equipment by healthcare facilities are the main topics of these updated technical guidelines. The organizations released these guidelines to raise awareness and adoption of radiation therapy in low- and middle-income nations.
Therefore, it is anticipated that during the forecast period, cancer screening programs and the adoption of standard guidelines will present profitable opportunities for expanding the North American radiotherapy market.
Factor Hampering North American Radiotherapy Market
Radiotherapy is responsible for the breakdown of DNA and the death of cancer cells. Along with cancer cells, the same effect is observed in healthy cells, leading to adverse reactions associated with radiotherapy. A few of the side effects become unnoticeable within a month of the radiation therapy; however, some of the effects might last for more than a month. Fatigue, skin problems, hair loss, low blood counts, headaches, nausea, vomiting, hearing loss, and seizures are among the prominently observed side effects of radiation therapy. According to a study published by NCBI in February 2021, the minimal tolerance dose of radiation therapy causes adverse reactions in approximately 5.0% of patients. However, the maximum tolerance dose causes adverse effects in ~50.0% of therapy receipts within or after five years of radiotherapy. Thus, the increased risk of occurrence of side effects associated with radiation therapy hamper the growth of the market.
 Based on type, the North America radiotherapy market is divided into product and software. The market is further divided on the basis of product into external-beam radiation therapy, internal radiation therapy, and systemic radiotherapy/radiopharmaceuticals. The product segment held the largest market share in 2023.
 By application, the market is segmented into breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, spine cancer, and others. The breast cancer segment held the largest share of the market in 2023.
 In terms of end user, the market is segmented into hospitals, radiation therapy centers, and specialty clinics. The hospitals segment held the largest market share in 2023.
North America Radiotherapy Market: Regional Overview
The substantial prevalence of cancer is expected to boost the demand for radiotherapy treatments in Canada in the coming years. In 2022, according to the Canadian Cancer Society, approximately 28,600 Canadian women were diagnosed with breast cancer, i.e., ~25% of all new cancer cases in women. It is also estimated that about one in eight Canadian women will develop breast cancer during their lifetime. The rising number of cancer cases is boosting the demand for advanced radiotherapy devices in the country. For instance, cancer patients in Nova Scotia will receive access to a novel form of radiation therapy in November 2023, which health authorities claim can revolutionize the quality of cancer care in North America. The Ethos therapy system spares neighboring organs from potential harm by using artificial intelligence imaging to identify tumor spots for radiation treatment. Further, Canadian organizations’ support services are likely to contribute to the market growth during the forecasted period. For instance, The Canadian Cancer Society is a national, community-based organization that focuses on eliminating cancer and boosting the quality of life of cancer patients.
A few of the major primary and secondary sources referred to while preparing the report on the North radiotherapy market are the World Bank Data, National Health Service (NHS), US Department of Health and Human Services (HHS), and WHO (World Health Organization).
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to our new research study on ” North America Radiotherapy Market Size and Forecast (2021–2031), Regional Share, Trend, and Growth Opportunity Analysis,” the market value is projected to grow from US$ 3.8 billion in 2023 to US$ 8.46 billion by 2031. The North America radiotherapy market is further anticipated to record a CAGR of 10.3% from 2022 to 2030. The North America radiotherapy market forecast presented in this report can help stakeholders in this marketplace plan their growth strategies.
Aging populations, lifestyle factors such as tobacco use, unhealthy diets, sedentary lifestyles, and environmental exposures to carcinogens are a few factors leading to the rise in cancer cases. With the rise in the number of people being diagnosed with cancer, there is an increasing need for efficient treatment choices such as radiation. Because of its many uses, radiation therapy is a vital component of a comprehensive cancer treatment plan. When surgery is not possible or as effective, radiotherapy might be used as the main treatment for cancer. It can also be administered in conjunction with immunotherapy, chemotherapy, or surgery to improve treatment results. Thus, the rising prevalence of cancer boosts the growth of the North America radiotherapy market.
The US holds a significant share of the North America radiotherapy market. The market growth in the US is driven by the growing digitalization of medical devices, increasing adoption of advanced medical device technologies, growing emphasis on improving treatment outcomes, and rising prevalence of cancer. According to a study published by the American Cancer Society in 2024, approximately 13,820 women in the US were diagnosed with cervical cancer.
An increasing number of business activities among market players contribute to the market growth. In November 2020, SOFIE Biosciences, Inc. and Jubilant Radiopharma entered a strategic partnership to expand its US production capacity and distribution channel. Further, in January 2021, Eckert & Ziegler announced its plan to build a cGMP facility for radiopharmaceutical services in the US.
There are several initiatives by the government and healthcare authorities to encourage the adoption of radiotherapy. Such strategies are likely to have a constructive impact on the US radiotherapy market. For instance, in June 2020, the American Society for Radiation Oncology (ASTRO) introduced new clinical guidelines regarding radiotherapy for nonmetastatic cervical cancer. The new guideline focuses on precisely implementing steps and processes to conduct radiation therapy. All these factors are expected to fuel the US radiotherapy market by 2031
Based on type, the North America radiotherapy market is divided into segmented into products and software. The products segment held largest market share in 2023.
By application, the market is segmented into breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, spine cancer, and others. The breast cancer segment held the largest share of the market in 2023.
In terms of end user, the market is categorized into hospitals, radiation therapy centers, and specialty clinics. The hospitals segment dominated the market in 2023.
Siemens Healthineers AG, Accuray Incorporated, Sumitomo Heavy Industries Ltd, Elekta AB, Hitachi Ltd, Koninklijke Philips NV, Brainlab AG, and PROTOM INTERNATIONAL. are a few key companies profiled in the North America radiotherapy market report.
Companies operating in the North America radiotherapy market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the North America radiotherapy market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall North America radiotherapy market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.
A few of the significant developments by key market players are listed below.
• Elekta received FDA approval for Elekta Esprit, a new Leksell Gamma Knife radiosurgery platform. This milestone makes the system available to clinicians and people with brain disease in the U.S., as well as opening the door to other countries where FDA approval is recognized. (Source: Elekta, Press Release, 2022)
• Royal Philips launched two new advances in MR-only workflows to advance head and neck cancer radiotherapy imaging and simulation. The company’s artificial intelligence (AI) enabled MRCAT Head and Neck radiotherapy application, which allows the use of MR as the sole or primary imaging modality for radiotherapy planning in the treatment of soft tissue tumors in the head and neck, along with the brain, pelvis and prostate, has received FDA 510(k) clearance and is commercially available in the U.S. (Source: Royal Philips, Press Release, 2022)
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the North America radiotherapy market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth market trends and outlook coupled with the factors driving the North America radiotherapy market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. Research Methodology
4. Radiotherapy Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Radiotherapy Market – Key Market Dynamics
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. Radiotherapy Market – North America Market Analysis
6.1 Radiotherapy – North America Market Overview
6.2 Radiotherapy – North America Market and Forecast to 2031
7. Radiotherapy Market – Revenue Analysis (USD Million) – By Type, 2021-2031
7.1 Overview
7.2 Products
7.2.1 External-Beam Radiation Therapy
7.2.2 Internal Radiation Therapy
7.2.3 Systemic Radiotherapy/Radiopharmaceuticals
7.3 Software
8. Radiotherapy Market – Revenue Analysis (USD Million) – By Application, 2021-2031
8.1 Overview
8.2 Breast Cancer
8.3 Lung Cancer
8.4 Prostate Cancer
8.5 Colorectal Cancer
8.6 Lymphoma
8.7 Liver Cancer
8.8 Thyroid Cancer
8.9 Brain Cancer
8.10 Cervical Cancer
8.11 Spine Cancer
8.12 Others
9. Radiotherapy Market – Revenue Analysis (USD Million) – By End User, 2021-2031
9.1 Overview
9.2 Hospitals
9.3 Radiation Therapy Centers
9.4 Specialty Clinics
10. Radiotherapy Market – Revenue Analysis (USD Million), 2021-2031 – Country Analysis
10.1 North America
10.1.1 North America Radiotherapy Market Overview
10.1.2 North America Radiotherapy Market Revenue and Forecasts to 2031
10.1.3 North America Radiotherapy Market Revenue and Forecasts and Analysis – By Type
10.1.4 North America Radiotherapy Market Revenue and Forecasts and Analysis – By Application
10.1.5 North America Radiotherapy Market Revenue and Forecasts and Analysis – By End User
10.1.6 North America Radiotherapy Market Revenue and Forecasts and Analysis – By Countries
10.1.6.1 United States Radiotherapy Market
10.1.6.1.1 United States Radiotherapy Market, by Type
10.1.6.1.2 United States Radiotherapy Market, by Application
10.1.6.1.3 United States Radiotherapy Market, by End User
10.1.6.2 Canada Radiotherapy Market
10.1.6.2.1 Canada Radiotherapy Market, by Type
10.1.6.2.2 Canada Radiotherapy Market, by Application
10.1.6.2.3 Canada Radiotherapy Market, by End User
10.1.6.3 Mexico Radiotherapy Market
10.1.6.3.1 Mexico Radiotherapy Market, by Type
10.1.6.3.2 Mexico Radiotherapy Market, by Application
10.1.6.3.3 Mexico Radiotherapy Market, by End User
11. Industry Landscape
11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments
12. Competitive Landscape
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration
13. Radiotherapy Market – Key Company Profiles
13.1 Siemens Healthineers AG
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
Note – Similar information would be provided for below list of companies
13.2 Accuray Incorporated
13.3 Sumitomo Heavy Industries Ltd
13.4 Elekta AB
13.5 Hitachi Ltd
13.6 Koninklijke Philips NV
13.7 Brainlab AG
13.8 PROTOM INTERNATIONAL
14. Appendix
14.1 Glossary
14.2 About the Research Team
14.3 Market Intelligence Cloud
LIST OF TABLES
Table 2. North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million)
Table 3. North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 4. North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million) – by Products
Table 5. North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 6. North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 7. North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million) – by Country
Table 8. United States: North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 9. United States: North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 10. United States: North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 11. United States: North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 12. Canada: North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 13. Canada: North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million) – by Products
Table 14. Canada: North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 15. Canada: North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 16. Mexico: North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 17. Mexico: North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million) – by Product
Table 18. Mexico: North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million) – by Application
Table 19. Mexico: North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 20. Recent Organic Growth Strategies in Radiotherapy Market
Table 21. Recent Inorganic Growth Strategies in the Radiotherapy Market
 
LIST OF FIGURES
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Radiotherapy Market Revenue (US$ Million), 2023–2031
Figure 5. North America Radiotherapy Market Share (%) – by Type, 2023 and 2031
Figure 6. Products: North America Radiotherapy Market– Revenue and Forecast to 2031 (US$ Million)
Figure 7. Software: North America Radiotherapy Market– Revenue and Forecast to 2031 (US$ Million)
Figure 8. North America Radiotherapy Market Share (%) – by Application, 2023 and 2031
Figure 9. Breast Cancer: North America Radiotherapy Market– Revenue and Forecast to 2031 (US$ Million)
Figure 10. Lung Cancer: North America Radiotherapy Market– Revenue and Forecast to 2031 (US$ Million)
Figure 11. Prostate Cancer: North America Radiotherapy Market– Revenue and Forecast to 2031 (US$ Million)
Figure 12. Colorectal Cancer: North America Radiotherapy Market– Revenue and Forecast to 2031 (US$ Million)
Figure 13. Lymphoma: North America Radiotherapy Market– Revenue and Forecast to 2031 (US$ Million)
Figure 14. Liver Cancer: North America Radiotherapy Market– Revenue and Forecast to 2031 (US$ Million)
Figure 15. Thyroid Cancer: North America Radiotherapy Market– Revenue and Forecast to 2031 (US$ Million)
Figure 16. Brain Cancer: North America Radiotherapy Market– Revenue and Forecast to 2031 (US$ Million)
Figure 17. Cervical Cancer: North America Radiotherapy Market– Revenue and Forecast to 2031 (US$ Million)
Figure 18. Spine Cancer: North America Radiotherapy Market– Revenue and Forecast to 2031 (US$ Million)
Figure 19. Others: North America Radiotherapy Market– Revenue and Forecast to 2031 (US$ Million)
Figure 20. North America Radiotherapy Market Share (%) – by End User, 2023 and 2031
Figure 21. Hospitals: North America Radiotherapy Market– Revenue and Forecast to 2031 (US$ Million)
Figure 22. Radiation Therapy Centers: North America Radiotherapy Market– Revenue and Forecast to 2031 (US$ Million)
Figure 23. Specialty Clinics: North America Radiotherapy Market– Revenue and Forecast to 2031 (US$ Million)
Figure 24. North America Radiotherapy Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 25. United States: North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 26. Canada: North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 27. Mexico: North America Radiotherapy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 28. Company Positioning and Concentration
Figure 29. Growth Strategies in Radiotherapy Market
The List of Companies – North America Radiotherapy Market
o Siemens Healthineers AG
o Accuray Incorporated
o Sumitomo Heavy Industries Ltd
o Elekta AB
o Hitachi Ltd
o Koninklijke Philips NV
o Brainlab AG
o PROTOM INTERNATIONAL
You must be logged in to post a review.
Reviews
There are no reviews yet.